This study describes the management of early stage non-seminomatous germ cell @entity5 of the testis in Edinburgh between 1970 and 1981. There were 69 @entity1 in clinical Stage I and 22 @entity1 in clinical Stage IIA. All were treated by orchiectomy and radiotherapy to the para-aortic nodes. Some of the @entity1 with Stage IIA disease received additional therapy. The overall 5-year actuarial survival rate was 83%. In a group of 52 @entity1 with Stage I disease who had had lymphography as part of their initial staging the 5-year actuarial survival rate was 94.2%. The overall relapse rate was 27/91 (29.7%). The relapse rate in State IIA disease was 11/22 (50%) and the 5-year actuarial survival rate was 64%. @entity1 with @entity5 beyond T1 had a significantly higher relapse rate than @entity1 with T1 @entity5 : 10/20 (50%) and 13/52 (25%) respectively. The histology of the primary @entity5 did not have a statistically significant influence upon relapse rate.

The management of early stage non-seminomatous germ cell XXXX of the testis: Edinburgh 1970-1981.

@entity5 :: ('MESH:D009369', 'Disease') :: ['primary tumours', 'tumours', 'tumour'] @entity1 :: ('9606', 'Species') :: ['Patients', 'patients']
@entity5 :: (MESH:D009369,Disease) :: ['tumours']
